Perrigo Company Profile



Odds of Distress

Check how we calculate scores
Equity ratings for Perrigo Company Plc are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting August 17, 2019 and ending today November 15, 2019. Click here to learn more.

Perrigo Company Profile

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 10600 people. more
NamePerrigo Company Plc
President CEO, DirectorMurray KesslerView All
Thematic Classification
Currently Active Investing Idea
  Macroaxis Picks
View All
Analyst Consensus
Macroaxis Advice
Bond Rating
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
Business AddressThe Sharp Building
Foreign Associate  Israel
ExchangeBATS Exchange
IndustryDrug Manufacturers - Specialty & Generic
Phone353 1 709 4000
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterSeptember 28, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestOctober 15, 2019
Perrigo Company Plc (PRGO) is traded on BATS Exchange in USA and employs 10,600 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 6.57 B. Perrigo Company conducts business under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 136.11 M outstanding shares of which 7.22 M shares are at this time shorted by private and institutional investors with about 7.42 trading days to cover. PERRIGO COMPANY currently holds about 401.1 M in cash with 360.12 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.95.
Check Perrigo Company Probability Of Bankruptcy

Ownership Allocation (%)

Perrigo Company Target Price Odds Analysis

Odds Below 49.37HorizonTargetOdds Above 49.37
24.79%30 days 49.37 75.06%
Based on normal probability distribution, the odds of Perrigo Company to move above current price in 30 days from now is about 75.06 (This Perrigo Company Plc probability density function shows the probability of Perrigo Company Stock to fall within a particular range of prices over 30 days) .

Perrigo Company Top Holders

Perrigo Company Risk Profiles

Perrigo Company Key Fundamentals

Perrigo Company Against Markets

Did you try this?

Run Fundamentals Comparison Now


Fundamentals Comparison

Compare fundamentals across multiple equities to find investing opportunities
All  Next Launch Module

Perrigo Company Upcoming and Recent Events

Perrigo Company Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportFebruary 27, 2017
Next Earnings ReportMay 15, 2017
Next Fiscal Quarter EndDecember 31, 2016
Next Fiscal Year EndFebruary 27, 2017
Last Quarter Report DateSeptember 30, 2016
Last Earning Anouncement DateDecember 31, 2015

Perrigo Company Corporate Filings

Perrigo Company SEC Reporting

Financial Statements and Exhibits. Other Events. Entry into a Material Definitive Agreement
Unclassified Corporate Event
Other Events
Submission of Matters to a Vote of Security Holders. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Perrigo Company Distributions to stockholders

Perrigo Company Corporate Directors

Gary Cohen Independent Director
Laurie Brlas Independent Director
Donal OConnor Independent Director
Additionally take a look at Your Equity Center. Please also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.